NEW YORK, NY / ACCESSWIRE / September 2, 2020 / The Law Offices of Vincent Wong announce that class actions have commenced on behalf of certain shareholders in the following companies. If you suffered a loss you have until the lead plaintiff deadline to request that the court appoint you as lead plaintiff. There will be no obligation or cost to you.
Honeywell International Inc. (NYSE:HON)
If you suffered a loss, contact us at: http://www.wongesq.com/pslra-1/honeywell-international-inc-loss-submission-form?prid=9020&wire=1
Lead Plaintiff Deadline: September 4, 2020
Class Period: February 9, 2018 - October 19, 2018
Allegations against HON include that: (1) Honeywell's Bendix Friction Materials ("Bendix") asbestos-related liability was greater than initially reported; (2) the Company maintained improper accounting practices in connection with its Bendix asbestos-related liability; and (3) as a result, Honeywell's public statements were materially false and misleading at all relevant times.
The GEO Group, Inc. (NYSE:GEO)
If you suffered a loss, contact us at: http://www.wongesq.com/pslra-1/the-geo-group-inc-loss-submission-form?prid=9020&wire=1
Lead Plaintiff Deadline: September 8, 2020
Class Period: February 27, 2020 - June 16, 2020
Allegations against GEO include that: (i) GEO Group maintained woefully ineffective COVID-19 response procedures; (ii) those inadequate procedures subjected residents of the Company's halfway houses to significant health risks; (iii) accordingly, the Company was vulnerable to significant financial and/or reputational harm; and (iv) as a result, the Company's public statements were materially false and misleading at all relevant times.
Vaxart, Inc. (NASDAQ:VXRT)
If you suffered a loss, contact us at: http://www.wongesq.com/pslra-1/vaxart-inc-loss-submission-form-2?prid=9020&wire=1
Lead Plaintiff Deadline: October 23, 2020
Class Period: June 25, 2020 - July 25, 2020
Allegations against VXRT include that: 1) Vaxart exaggerated the prospects of its COVID-19 vaccine candidate, including its purported role or involvement in Operation Warp Speed ('OWS'), a program which commits the federal government to massive funding for the development of COVID-19 vaccines; 2) Vaxart's COVID-19 vaccine candidate had no reasonable prospect for mass production and marketing and was not among the companies chosen to receive significant financial support from OWS to produce hundreds of millions of vaccine doses; and 3) Vaxart's COVID-19 vaccine candidate was merely selected to participate in preliminary U.S. government studies to determine potential areas for possible OWS partnership and support.
To learn more contact Vincent Wong, Esq. either via email firstname.lastname@example.org or by telephone at 212.425.1140.
Vincent Wong, Esq. is an experienced attorney who has represented investors in securities litigations involving financial fraud and violations of shareholder rights. Attorney advertising. Prior results do not guarantee similar outcomes.
Vincent Wong, Esq.
39 East Broadway
New York, NY 10002
SOURCE: The Law Offices of Vincent Wong
View source version on accesswire.com: